- Home
- MIND vs COEP Comparison
MIND vs COEP Comparison
Compare MIND & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIND
- COEP
- Stock Information
- Founded
- MIND 1987
- COEP 2017
- Country
- MIND United States
- COEP United States
- Employees
- MIND N/A
- COEP N/A
- Industry
- MIND Industrial Machinery/Components
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MIND Industrials
- COEP Health Care
- Exchange
- MIND Nasdaq
- COEP Nasdaq
- Market Cap
- MIND 67.5M
- COEP 72.1M
- IPO Year
- MIND 1994
- COEP N/A
- Fundamental
- Price
- MIND $8.66
- COEP $17.71
- Analyst Decision
- MIND
- COEP
- Analyst Count
- MIND 0
- COEP 0
- Target Price
- MIND N/A
- COEP N/A
- AVG Volume (30 Days)
- MIND 265.5K
- COEP 44.7K
- Earning Date
- MIND 12-12-2025
- COEP 11-14-2025
- Dividend Yield
- MIND N/A
- COEP N/A
- EPS Growth
- MIND N/A
- COEP N/A
- EPS
- MIND 2.54
- COEP N/A
- Revenue
- MIND $48,612,000.00
- COEP $500,996.00
- Revenue This Year
- MIND $2.33
- COEP N/A
- Revenue Next Year
- MIND N/A
- COEP N/A
- P/E Ratio
- MIND $3.58
- COEP N/A
- Revenue Growth
- MIND 27.70
- COEP N/A
- 52 Week Low
- MIND $3.75
- COEP $2.31
- 52 Week High
- MIND $14.50
- COEP $19.19
- Technical
- Relative Strength Index (RSI)
- MIND 35.90
- COEP 65.07
- Support Level
- MIND $8.49
- COEP $15.52
- Resistance Level
- MIND $9.39
- COEP $18.00
- Average True Range (ATR)
- MIND 0.99
- COEP 1.25
- MACD
- MIND -0.52
- COEP 0.34
- Stochastic Oscillator
- MIND 2.50
- COEP 92.40
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.